Stock Track | Medpace Plunges 16.41% in After-Hours Trading Following Investor Lawsuit Over Alleged Misleading Guidance

Stock Track04:32

Medpace Holdings Inc. (MEDP) experienced a significant after-hours plunge of 16.41% on Wednesday, despite reporting first-quarter revenue that exceeded analyst expectations.

The sharp decline appears to be driven by investor concerns following news that the company faces a lawsuit over alleged misleading book-to-bill guidance. According to the report, Medpace told investors cancellations were "well behaved" and that a 1.15 book-to-bill target remained achievable for the second half of 2025, but these statements are now being challenged in court.

This legal development overshadowed the company's positive quarterly results, which included a 26.5% year-over-year revenue increase and net new business awards growth of 23.7%. The lawsuit raises questions about the credibility of the company's future performance targets and guidance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1178135472?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-23 04:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1178135472","market":"nz","top_or_hot":-1,"title":"Stock Track | Medpace Plunges 16.41% in After-Hours Trading Following Investor Lawsuit Over Alleged Misleading Guidance","media":"Stock Track","content":"<p>Medpace Holdings Inc. (MEDP) experienced a significant after-hours plunge of 16.41% on Wednesday, despite reporting first-quarter revenue that exceeded analyst expectations.</p><p>The sharp decline appears to be driven by investor concerns following news that the company faces a lawsuit over alleged misleading book-to-bill guidance. According to the report, Medpace told investors cancellations were \"well behaved\" and that a 1.15 book-to-bill target remained achievable for the second half of 2025, but these statements are now being challenged in court.</p><p>This legal development overshadowed the company's positive quarterly results, which included a 26.5% year-over-year revenue increase and net new business awards growth of 23.7%. The lawsuit raises questions about the credibility of the company's future performance targets and guidance.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Medpace Plunges 16.41% in After-Hours Trading Following Investor Lawsuit Over Alleged Misleading Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Medpace Plunges 16.41% in After-Hours Trading Following Investor Lawsuit Over Alleged Misleading Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-23 04:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Medpace Holdings Inc. (MEDP) experienced a significant after-hours plunge of 16.41% on Wednesday, despite reporting first-quarter revenue that exceeded analyst expectations.</p><p>The sharp decline appears to be driven by investor concerns following news that the company faces a lawsuit over alleged misleading book-to-bill guidance. According to the report, Medpace told investors cancellations were \"well behaved\" and that a 1.15 book-to-bill target remained achievable for the second half of 2025, but these statements are now being challenged in court.</p><p>This legal development overshadowed the company's positive quarterly results, which included a 26.5% year-over-year revenue increase and net new business awards growth of 23.7%. The lawsuit raises questions about the credibility of the company's future performance targets and guidance.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MEDP","symbol_name":"Medpace Holdings Inc.","start_time":0,"source_url":"","article_id":"1178135472","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1178135472","pubTimestamp":1776889960,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Medpace Holdings Inc. (MEDP) experienced a significant after-hours plunge of 16.41% on Wednesday, despite reporting first-quarter revenue that exceeded analyst expectations.The sharp decline appears...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MEDP":"Medpace Holdings Inc."},"translate_title":"个股追踪|Medpace盘后交易暴跌16.41%因涉嫌误导指引遭投资者诉讼","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MEDP":1},"content_text":"Medpace Holdings Inc. (MEDP) experienced a significant after-hours plunge of 16.41% on Wednesday, despite reporting first-quarter revenue that exceeded analyst expectations.The sharp decline appears to be driven by investor concerns following news that the company faces a lawsuit over alleged misleading book-to-bill guidance. According to the report, Medpace told investors cancellations were \"well behaved\" and that a 1.15 book-to-bill target remained achievable for the second half of 2025, but these statements are now being challenged in court.This legal development overshadowed the company's positive quarterly results, which included a 26.5% year-over-year revenue increase and net new business awards growth of 23.7%. The lawsuit raises questions about the credibility of the company's future performance targets and guidance.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1178135472","isCrawlerRequest":true}